Amarin Corporation/$AMRN
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Amarin Corporation
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.
- Ticker
- $AMRN
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 80
- Headquarters
- Dublin, Ireland
- Website
- www.amarincorp.com
AMRN Metrics
BasicAdvanced
$247M
-
-$0.91
0.77
-
Price and volume
Market cap
$247M
Beta
0.77
52-week high
$17.31
52-week low
$11.25
Average daily volume
79K
Financial strength
Current ratio
3.499
Quick ratio
2.492
Long term debt to equity
0.012
Total debt to equity
0.017
Interest coverage (TTM)
-3,514.57%
Profitability
EBITDA (TTM)
-21.986
Gross margin (TTM)
40.94%
Net profit margin (TTM)
-10.87%
Operating margin (TTM)
-13.97%
Effective tax rate (TTM)
-11.75%
Revenue per employee (TTM)
$2,200,000
Management effectiveness
Return on assets (TTM)
-2.38%
Return on equity (TTM)
-4.24%
Valuation
Price to revenue (TTM)
1.394
Price to book
0.56
Price to tangible book (TTM)
0.57
Price to free cash flow (TTM)
6.546
Free cash flow yield (TTM)
15.28%
Free cash flow per share (TTM)
1.789
Growth
Revenue change (TTM)
-22.33%
Earnings per share change (TTM)
-78.19%
3-year revenue growth (CAGR)
-18.26%
10-year revenue growth (CAGR)
4.08%
3-year earnings per share growth (CAGR)
-29.26%
10-year earnings per share growth (CAGR)
-20.14%
What the Analysts think about AMRN
Analyst ratings (Buy, Hold, Sell) for Amarin Corporation stock.
Analyst projections of the future price of Amarin Corporation stock.
AMRN Financial Performance
Revenues and expenses
AMRN Earnings Performance
Company profitability
Upcoming events
No upcoming events
AMRN News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.